Recalls for Schizophrenia

Clozapine: Drug Safety Communication - FDA Modifies Monitoring for Neutropenia; Approves New Shared REMS Program
09/15/2015 Medical Recall

Enhanced labeling explaining how to monitor patients for neutropenia/manage clozapine treatment. Approval of new, shared REMS.

  • Category
    Schizophrenia